期刊文献+

口服胰岛素纳米粒的吸收机制

Absorptive mechanisms of oral insulin nanoparticles
原文传递
导出
摘要 胰岛素口服给药可以显著改善糖尿病患者的生活质量,然而,胃肠道中各种生理障碍限制了胰岛素的口服吸收。将胰岛素用特定的聚合纳米材料封装可增加口服胰岛素的生物利用度。载胰岛素纳米粒可通过细胞旁路和跨细胞途径穿过肠上皮细胞层,其吸收机制可能是通过增加与黏膜相互作用或可逆性打开相邻细胞紧密连接。 Oral delivery of therapeutic insulin can significantly improve the quality of life of diabetic patients. However,oral absorption of insulin is limited by various physiological barriers in the gastrointestinal tract. The encapsulation of insulin into specific polymer-based nanoparticles can increase the oral bioavailability of insulin. Nanoparticles can transport across the intestinal epithelium via the paracellular route or transcellular route. The absorptive mechanisms of insulin delivered by nanoparticles may increase the interactions with the intestinal mucosa or open tight Junctions between contiL, uous enithelial cell~ r^versiblv.
出处 《国际内分泌代谢杂志》 2015年第4期275-279,共5页 International Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目(21201149) 江苏省自然科学基金资助项目(BK2012259) 扬州市八大产业科技攻关项目(YZ2010083)
关键词 胰岛素 口服给药 纳米粒 Insulin Oral delivery Nanoparticles
  • 相关文献

参考文献31

  • 1Rekha MR,Sharma CP.Oral delivery of therapeutic protein/ peptide for diabetes-future perspectives J].Int J Pharm, 2013, 440( 1 ) :48-62.
  • 2Mukhopadhyay P, Chakraborty S, Bhattacharya S, et al.pH- sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery [J].Int J Biol Macromol,2015,72: 640-648.
  • 3Ensign LM,Cone R,Hanes J.Oral drug delivery with polymeric nanoparticles:the gastrointestinal mucus barriers [J].Adv Drug Deliv lRev, 2012,64 (6) : 557-570.
  • 4Gonz61ez-Mariscal L, Domfnguez-Calder6n A,Raya-Sandino A, et al.Tight junctions and the regulation of gene expression[J]. Semin Cell Dev Biol,2014,36:213-223.
  • 5Pawar VK, Meher JG, Singh Y, et al.Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives [J].J Control Release,2014, 196:168-183.
  • 6Yun Y, Cho YW, Park K.Nanoparticles for oral delivery : targeted nanoparticles with peptidic ligands for oral protein delivery [J]. Adv Drug Deliv Rev,2013,65(6) : 822-832.
  • 7Pridgen EM,Alexis F,Farokhzad OC.Polymeric nanoparticle technologies for oral drug delivery[J].Clin Gastmenterol Hepatol, 2014,12(10) : 1605-1610.
  • 8Feng C,Sun G,Wang Z,et al.Transport mechanism of doxoru- bicin loaded chitosan based nanogels across intestinal epithelium [J]. Eur J Pharm Biopharm, 2014,87( 1 ) : 197-207.
  • 9Antunes F, Andrade F, Ferreira D, et al.Models to predict intestinal absorption of therapeutic peptides and proteins [J]. Curr Drug Metab, 2013,14( 1 ) :4-20.
  • 10Yeh TH, Hsu LW, Tseng MT, et al.Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening [J].Biomaterials, 2011,32(26) :6164-6173.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部